Axsome Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Axsome Therapeutics

05/08/2024 14:32

* Axsome Therapeutics Inc  AXSM.OQ  reported a quarterly
adjusted
loss of $1.67​​ per share for the quarter ended in June, lower
than the same quarter last year, when the company reported EPS
of $-1.54.  The mean expectation of seventeen analysts for the
quarter was for a loss of $1.33 per share. Wall Street expected
results to range from $-1.67 to -97 cents per share.
    * Revenue rose 88% to $86.52 million from a year ago;
analysts
expected $86.92 million. 
    * Axsome Therapeutics Inc's reported EPS for the quarter was
a
loss of $1.67​.
    * The company reported a quarterly loss of $79.35 million.
    * Axsome Therapeutics Inc shares had risen by 4.9% this
quarter and gained 6.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 7.2%
in the last three months.​ 
    * In the last 30 days, three analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 16 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Axsome
Therapeutics Inc is $117.50 
This summary was machine generated from LSEG data August 5 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -1.33          -1.67          Missed
 Mar. 31 2024      -1.20          -1.44          Missed
 Dec. 31 2023      -1.17          -2.08          Missed
 Sep. 30 2023      -1.20          -1.32          Missed